Effect of SGLT2 inhibitors on microscopic hematuria in IgA nephropathy: a review from the perspective of disease activity biomarkers - Top-Institutions - MDSpire

Effect of SGLT2 inhibitors on microscopic hematuria in IgA nephropathy: a review from the perspective of disease activity biomarkers

  • By

  • Junhua Yang

  • Zesheng Chen

  • Haochuan Han

  • Can Li

  • Dafeng Yue

  • May 29, 2026

  • 0 min

Share

Top Institutions in Nephrology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Nephrology

  • #2

    Columbia University Irving Medical Center
    Columbia University Irving Medical Center

    New York, New York

    Key Differentiators

    • Nephrology

Original Source(s)

Effect of SGLT2 inhibitors on microscopic hematuria in IgA nephropathy: a review from the perspective of disease activity biomarkers

  • by Junhua Yang, Zesheng Chen, Haochuan Han, Can Li, Dafeng Yue

  • May 29, 2026

Related Content

Editorial: Enhanced recovery after vascular surgery: state of the art and future perspectives

Artificial intelligence-based quantification of retinal microvascular biomarkers from fundus photography of chronic kidney disease: a case-control study

Programmed cell death in gouty nephropathy: molecular mechanisms and therapeutic implications